Evaluation of PEGylated Doxorubicin Hydrochloride Liposome Injection (Duomeisu) in the treatment of relapsed and refractory Ovarian Cancer: A Single-arm, Open, Multicenter clinical study.
Latest Information Update: 29 Jan 2020
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Carcinoma; Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
Most Recent Events
- 01 Oct 2019 New trial record